Ennis, Inc.: Form 10-Q for the period ended Aug 31, 2023
Filed with the SEC on Oct 3, 2023 and accepted by EDGAR at Oct 3, 2023, 19:20 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-06-01 to 2023-08-31 | $106.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-03-01 to 2023-08-31 | $218.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-06-01 to 2023-08-31 | $73.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-03-01 to 2023-08-31 | $150.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-06-01 to 2023-08-31 | $33.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-03-01 to 2023-08-31 | $67.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-06-01 to 2023-08-31 | $18.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-03-01 to 2023-08-31 | $36.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-06-01 to 2023-08-31 | $14.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-03-01 to 2023-08-31 | $30.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-06-01 to 2023-08-31 | $4.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-03-01 to 2023-08-31 | $8.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-06-01 to 2023-08-31 | $10.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-03-01 to 2023-08-31 | $22.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-06-01 to 2023-08-31 | $0.42 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-03-01 to 2023-08-31 | $0.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-06-01 to 2023-08-31 | $0.42 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-03-01 to 2023-08-31 | $0.87 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-06-01 to 2023-08-31 | 26,050,983 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-03-01 to 2023-08-31 | 26,010,739 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-03-01 to 2023-08-31 | $34.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-03-01 to 2023-08-31 | $3.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2023-03-01 to 2023-08-31 | $12.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2023-03-01 to 2023-08-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-08-31 | $100.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-08-31 | $198.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-08-31 | $398.9m | us-gaap:Assets |
| Current liabilities | At period end2023-08-31 | $35.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-08-31 | $55.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-08-31 | $343.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-051455. Last ingested by Listed: Oct 24, 2026, 14:52 ET. Listed shows no prices and gives no investment advice.